TIAM1 and Familial prostate cancer: In conclusion, the present study with up to 14.4-year follow-up shows that strong Tiam1 overexpression in prostate cancer relative to the corresponding benign prostate epithelial cells correlates with aggressive disease and is an independent prognostic indicator of disease recurrence.